Some individuals may also report changes in appetite, mood swings, or sleep disturbances, although these are less common
STEP UP Phase 3 Trial Design The sNDA incorporates data from the STEP UP trial (NCT05646706), a 72-week, randomized, double-blind, placebo- and active-controlled superiority study involving 1,407 adults with obesity (BMI 30 kg/m)
X., Nakamura, N., Mure, M., Klinman, J
The mechanism of action, whereby GLP-1 agonists mimic the natural hormone to regulate appetite (Nauck and Meier, 2016)
One key difference between liraglutide and tirzepatide is how often you take the medications